Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Libera Bio
Krakow, Poland
B
- Employees
2018
Key takeaway
Libera Bio is a biopharmaceutical company focused on developing innovative therapeutics for cancer, utilizing its MPN Technology® to deliver large molecules like antibodies. This approach aims to tackle "undruggable" intracellular targets, which may include bispecific antibodies as a potential therapeutic strategy.
Reference
Core business
Libera Bio | Addressing undruggable intracellular targets in oncology
Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
Mabion S.A.
Konstantynów Łódzki, Poland
B
251-500 Employees
2007
Key takeaway
The company highlights its expertise in biologics, including the development and manufacturing of innovative therapies like CAR-T products for hematologic malignancies. Their experience with biosimilars, such as Wezlana®, which has received FDA approval, underscores their capability in addressing complex therapeutic needs.
Reference
Core business
Home page - Mabion
BVI
Gdańsk, Poland
B
1-10 Employees
-
Key takeaway
The BioVentures Institute Ltd. specializes in advanced molecular biotechnology, including the development of innovative products and techniques such as DNA recombination and gene cloning. With extensive experience in biotechnology and a focus on applying new technologies, the company is well-positioned to contribute to the advancement of biologics and therapeutic innovations.
Reference
Core business
Bioventures Institute - Molecular Biotechnology Company
The BioVentures Institute Ltd. is an innovation-driven molecular biotechnology company, conducting applied research, product development and production, utilizing advanced genetic engineering, molecular biology, biochemical and microbiological technologies.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Polpharma Biologics
Gdańsk, Poland
B
- Employees
-
Key takeaway
Polpharma Biologics is focused on developing the next generation of biosimilars, enhancing access to vital therapies. Their state-of-the-art facilities and commitment to quality position them as a leader in the biotechnology sector, dedicated to delivering innovative solutions.
Reference
Core business
Polpharma Biologics
Polpharma Biologics is one of the most modern biotechnology companies with state-of-the-art facilities across Europe. Our customized CDMO services are available for both biosimilars and innovative molecules, including next-generation biologics.
NaNoEXPO - Next Generation Therapeutics
Gdańsk, Poland
B
1-10 Employees
2016
Key takeaway
The NaNoEXPO system from the biotech start-up NaNoExpo offers innovative solutions for the rapid production of virus-like particles (VLPs) and other biological nanostructures, which can be tailored to present specific epitopes or peptides. This technology is designed to accelerate the development of diagnostic and therapeutic tools, including vaccines, by enabling researchers to test various antigens efficiently.
Reference
Service
Service - NaNoEXPO - Next Generation Therapeutics
Our solutions involve: Virus-like particles presenting multiple copies of linear epitopes on their surface – the platform is optimized for different prokaryotic and eukaryotic expression systems. Self-assembling biological nanostructures presenting conformational epitopes on their surface. Biological nanostructures with internal motifs for encapsulation and delivery of therapeutic mRNA.
A4BEE
Wrocław, Poland
B
51-100 Employees
2016
Key takeaway
A4BEE is a global technology partner that supports top-tier biotech organizations by providing disruptive innovation and strategies, making it well-positioned to enhance the development and success of bispecific antibodies within the biotech sector.
Reference
Core business
A4BEE | Delivering Meaningful Innovation
A4BEE is a global technology partner that enables the sustained success of top-tier biotech organizations by delivering meaningful innovation.
Clinical Consulting Poland
Tychy, Poland
B
11-50 Employees
2004
Key takeaway
The company offers specialized clinical trial management services that could be beneficial for the development and testing of bispecific antibodies. Their expertise in complex clinical trial designs and commitment to delivering quality clinical data on time and within budget underscores their capability to support innovative therapeutic approaches.
Reference
Service
EMA Orphan Drug Designation – Clinical Consulting
Nomi Biotech Corporation
Suchy Las, Poland
B
1-10 Employees
2018
Key takeaway
Nomi Biotech Corporation specializes in the development of proprietary nutraceutical formulations, including a patented curcuminoids formulation that could be relevant in the context of innovative therapeutic approaches like bispecific antibodies.
Reference
Product
Products - Nomi Biotech
CORMAY DIAGNOSTICS
Korczów, Poland
B
51-100 Employees
1985
Key takeaway
Cormay Diagnostics focuses on providing innovative IVD solutions that enhance patient care and reduce antibiotic resistance. Their experience in manufacturing high-quality diagnostic products suggests a commitment to trustworthiness and effectiveness in medical testing.
Reference
Product
B50-IgG - IMMUNOGLOBULIN G - Products Cormay Diagnostics
Genegoggle
Warsaw, Poland
B
11-50 Employees
-
Key takeaway
Genegoggle is a precision medicine biotech company focused on discovering novel therapeutics and enhancing the understanding of the human genome through innovative approaches. Their work in multi-dimensional genomic and epigenetic elements may contribute to advancements in targeted therapies, including potential applications related to bispecific antibodies.
Reference
Service
Services | Genegoggle
Technologies which have been searched by others and may be interesting for you:
The Bispecific Antibody industry in Poland presents several key considerations for those interested in this growing field. Regulatory frameworks in Poland are aligned with EU directives, which means that companies must navigate complex approval processes for new therapies. Understanding these regulations is crucial for successful market entry. The competitive landscape features both established pharmaceutical companies and emerging biotechs, making it essential to identify potential collaborators and competitors. Research and development in bispecific antibodies face challenges such as high production costs and ensuring efficacy without compromising safety. However, the opportunities in Poland are significant, driven by a skilled workforce and increasing investment in biopharmaceutical research. The country’s strategic location in Europe also facilitates access to broader markets. Moreover, environmental concerns related to biomanufacturing processes and waste management should be taken into account, as sustainability practices are becoming increasingly important. The global market relevance of bispecific antibodies is on the rise, with their potential application in treating various diseases, including cancer and autoimmune disorders. Hence, a comprehensive understanding of these factors can provide valuable insights for anyone looking to engage with the bispecific antibody sector in Poland.
Some interesting numbers and facts about your company results for Bispecific Antibody
| Country with most fitting companies | Poland |
| Amount of fitting manufacturers | 31 |
| Amount of suitable service providers | 26 |
| Average amount of employees | 51-100 |
| Oldest suiting company | 1985 |
| Youngest suiting company | 2018 |
Some interesting questions that has been asked about the results you have just received for Bispecific Antibody
What are related technologies to Bispecific Antibody?
Based on our calculations related technologies to Bispecific Antibody are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Bispecific Antibody?
The most represented industries which are working in Bispecific Antibody are Biotechnology, IT, Software and Services, Other, Medical, Pharmaceuticals
How does ensun find these Bispecific Antibody Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.